1h Free Analyst Time
The high throughput screening (HTS) market is forecasted to grow by USD 19.9 bn during 2023-2028, accelerating at a CAGR of 12.12% during the forecast period. The report on the high throughput screening (HTS) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in R and D investments, increasing prevalence of chronic diseases, and patent expiration of drugs.
The high throughput screening (HTS) market is segmented as below:
By Application
- Target identification and validation
- Primary and secondary screening
- Toxicology assessment
- Stem cell research
By End-user
- Pharmaceutical and biotechnology companies
- Academic and research institutes
- CROs
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the high throughput screening (HTS) market covers the following areas:
- High throughput screening (HTS) market sizing
- High throughput screening (HTS) market forecast
- High throughput screening (HTS) market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global high throughput screening (hts) market: Agilent Technologies Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is patent expiration of drugs.`
According to the report, one of the major drivers for this market is the rise in R&D investments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Aurora Biomed Inc.
- Axxam Spa
- Beckman Coulter Inc.
- Bio Rad Laboratories Inc.
- Biomat Srl
- BMG LABTECH GmbH
- Charles River Laboratories International Inc.
- Corning Inc.
- Danaher Corp.
- DIANA Biotechnologies s.r.o
- HighRes Biosolutions
- JSR Life Sciences LLC
- Lonza Group Ltd.
- Merck KGaA
- NanoTemper Technologies GmbH
- PerkinElmer Inc.
- Sygnature Discovery Ltd.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
